Limba
|
BC1618 is an orally active Fbxo48inhibitor that stimulates adenosine monophosphate (AMP)-activated protein kinase (Ampk)-dependent signaling. BC1618 promotes mitochondrial fission, facilitates autophagyand improves hepatic insulin sensitivity.
Price | 992,00 RON (preturile sunt fara TVA) |
---|---|
Description |
BC1618 is an orally active Fbxo48inhibitor that stimulates adenosine monophosphate (AMP)-activated protein kinase (Ampk)-dependent signaling. BC1618 promotes mitochondrial fission, facilitates autophagyand improves hepatic insulin sensitivity. |